Question:
In patients with early or mild stage Alzheimer’s dementia how effective is memantine when compared to standard care in slowing the progression of dementia and/or delaying admittance to institutionalised care.
Answer:
The limited evidence currently available does not support the
routine use of memantine to delay disease progression in patients
with early or mild stage Alzheimer's dementia.
To view the full summary, click the Download Document
link to the right.
To view relevant national guidelines, click Related
Links, below.
To view the Cochrane review which is included in this summary,
click Related Documents, below.